Vescor Therapeutics
Newyork
About Vescor Therapeutics
Vescor Therapeutics is an autophagy-targeted therapeutic designed to assist in cancer treatment. It offers clinical studies that have now shown a requirement for autophagy in sustaining tumour growth as well as the mechanism of resistance to a number of currently used therapies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jan 2017)
- Website: vescortx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/vescor-therapeutics-2847263 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.